Qualigen Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Qualigen Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Qualigen Therapeutics Inc
Rating: 0.53850
Author: Trendlyne DVM scores

about

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical th...

1.68 -0.06 (-3.45%)

83.92% Fall from 52W High

9,045

XNAS Volume

XNAS 04 Sep, 2025 12:21 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Bearish

21.5 / 100

No estimates available

Qualigen Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Qualigen Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical th...

83.92% Fall from 52W High

SWOT Analysis

Qualigen Therapeutics Inc Live Price Chart